Droplet Digital PCR as a First-Line Detection Tool in the Genetic Diagnosis of Vascular Anomalies
Lane, T.; Green, T. E.; Garza, D.; Brown, N. J.; de Silva, M. G.; Bennett, M. F.; Tubb, C.; Macdonald, S. M. W.; Gascoigne, A.; Phillips, R. J.; Slavin, J.; D'Arcy, C.; MacGregor, D.; Clifford, A.; Pathmanathan, L.; Robertson, S. J.; Bekhor, P.; Simpson, J.; Gooley, S.; Scheffer, I. E.; Berkovic, S. F.; Penington, A. J.; Hildebrand, M.
Show abstract
Targeted precision therapies are increasingly used in the treatment of individuals with vascular anomalies (VAs). This increases the need for rapid, accurate and inexpensive genetic diagnosis. Droplet digital polymerase chain reaction (ddPCR) is an alternative to next-generation sequencing (NGS), permitting rapid, highly sensitive interrogation of recurrent pathogenic mosaic variants. We examined the feasibility of ddPCR as a primary diagnostic tool in a large cohort of individuals with VAs. Lesional tissue was collected for ddPCR of up to 46 recurrent pathogenic variants across 16 genes associated with VAs. Specimens were assessed on a subset of assays for each individual based on clinical phenotype. Most individuals who had negative ddPCR results went on to high-depth gene panel or deep exome NGS, or Sanger sequencing. Here we report the phenotypic and molecular findings for 78 newly recruited and tested individuals in addition to the 60 individuals already reported from our cohort. The overall diagnostic yield for our cohort when combined with individuals previously reported was 104/138 (75%). Of 138 individuals tested, recurrent pathogenic variants were detected in 71 (51%) on ddPCR. Variants were most frequently identified in PIK3CA (n=28), TEK (n=18), GNAQ (n=12), or MAP2K1 (n=7). In a further 33 individuals, pathogenic variants were identified on NGS or Sanger sequencing. Our findings indicate that ddPCR is an efficient method achieving a high diagnostic yield in our cohort when used prior to sequencing.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Early Diagnosis of Vascular Ehlers-Danlos Syndrome Through AI-Powered Facial Analysis: Results from the Montalcino Aortic Consortium 92%
- Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing 90%
- 3-hour genome sequencing and targeted analysis to rapidly assess genetic risk 89%
Similar papers in this journal
- Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level 90%
- Utility of genome sequencing and group-enrichment to support splice variant interpretation in Marfan syndrome 90%
- One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation 90%
Similar papers in this journal
- Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Biallelic Loss of ENG or ACVRL1 91%
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 90%
- Returning Actionable Genomic Results in a Research Biobank: Analytic Validity, Clinical Implementation and Resource Utilization 90%
Similar papers in this journal
- GeneTerpret: a customizable multilayer approach to genomic variant prioritization and interpretation 90%
- Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk 89%
- Quality of Whole Genome Sequencing from Blood versus Saliva Derived DNA in Cardiac Patients 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.